Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Neurosurg Rev. 2023 May 5;46(1):106. doi: 10.1007/s10143-023-02020-5.
Endoscopic assistance for aneurysm clipping and its possible benefits have been suggested in previous studies, but its clinical significance has not been fully elucidated. This study aimed to present the efficacy of endoscopy-assisted clipping in reducing post-clipping cerebral infarction (PCI) and clinical outcomes via a historical comparison of patients in our institution from January 2020 to March 2022. A total of 348 patients were included, 189 of whom underwent endoscope-assisted clipping. The overall incidence of PCI was 10.9% (n = 38); it was 15.7% (n = 25) before applying endoscopic assistance and decreased to 6.9% (n = 13) after endoscope application (p = 0.010). The application of a temporary clip (odds ratio [OR]: 2.673, 95% confidence interval [CI]: 1.291-5.536), history of hypertension (OR: 2.176, 95% CI: 0.897-5.279), history of diabetes mellitus (OR: 2.530, 95% CI: 1.079-5.932), and current smoker (OR: 3.553, 95% CI: 1.288-9.802) were independent risk factors of PCI, whereas endoscopic assistance was an independent inverse risk factor (OR: 0.387, 95% CI: 0.182-0.823). Compared to the location of the unruptured intracranial aneurysms, internal carotid artery aneurysms showed a significant decrease in the incidence of PCI (5.8% vs. 22.9%, p = 0.019). In terms of clinical outcomes, PCI was a significant risk factor for longer admission duration, intensive care unit stay, and poor clinical outcomes. However, endoscopic assistance itself was not a significant risk factor for clinical outcomes on the 45-day modified Rankin Scale. In this study, we noted the clinical significance of endoscope-assisted clipping in preventing PCI. These findings could reduce the incidence of PCI and improve the understanding of its mechanisms of action. However, a larger and longer-term study is required to evaluate the benefits of endoscopy on clinical outcomes.
内镜辅助夹闭术在动脉瘤夹闭中的作用及其可能的益处已在前瞻性研究中得到证实,但其实践意义尚未得到充分阐明。本研究旨在通过回顾性分析我院 2020 年 1 月至 2022 年 3 月期间的病例,探讨内镜辅助夹闭术在降低夹闭术后脑梗死(post-clipping cerebral infarction,PCI)发生率和改善临床预后方面的效果。
本研究共纳入 348 例患者,其中 189 例行内镜辅助夹闭术。总体 PCI 发生率为 10.9%(n=38);应用内镜辅助前为 15.7%(n=25),应用后降低至 6.9%(n=13)(p=0.010)。应用临时夹(比值比[OR]:2.673,95%置信区间[CI]:1.291-5.536)、高血压病史(OR:2.176,95%CI:0.897-5.279)、糖尿病病史(OR:2.530,95%CI:1.079-5.932)和当前吸烟者(OR:3.553,95%CI:1.288-9.802)是 PCI 的独立危险因素,而内镜辅助是独立的保护因素(OR:0.387,95%CI:0.182-0.823)。与未破裂颅内动脉瘤的位置相比,颈内动脉动脉瘤的 PCI 发生率显著降低(5.8% vs. 22.9%,p=0.019)。在临床预后方面,PCI 是住院时间延长、入住重症监护病房和预后不良的显著危险因素。然而,内镜辅助本身并不是 45 天改良 Rankin 量表评分的临床预后的显著危险因素。
在本研究中,我们注意到内镜辅助夹闭术在预防 PCI 方面的临床意义。这些发现可以降低 PCI 的发生率,并加深对其作用机制的理解。然而,还需要更大规模和更长期的研究来评估内镜在临床结局方面的获益。